TY - JOUR
T1 - Characteristics of a treatment-seeking population in outpatient addiction treatment centers in Mexico
AU - Marín-Navarrete, Rodrigo
AU - Templos-Nuñez, Liliana
AU - Eliosa-Hernández, Angélica
AU - Villalobos-Gallegos, Luis
AU - Fernández-Mondragón, José
AU - Pérez-López, Alejandro
AU - Galván-Sosa, Diana
AU - Verdeja, Rosa E.
AU - Alonso, Elizabeth
AU - Feaster, Daniel J.
AU - Horigian, Viviana E.
N1 - Funding Information:
Research Assistant Professor of Public Health Sciences, at the University of Miami, Miller School of Medicine. She is the Executive Director of the Florida Node Alliance, one of the 13 centers of the National Drug Abuse Treatment Clinical Trials Network, supported by NIDA. With her extensive clinical trials experience, she is the PI for a federally funded grant from the US Department of State to train and mentor the National Institute of Psychiatry in Mexico to develop the research infrastructure and technological capabilities to conduct effectiveness drug abuse treatment clinical trials with the technology used in NIDA’s National Drug Abuse Treatment Clinical Trials Network.
Funding Information:
A special acknowledgment for their institutional support in this study: Consejo Nacional Contra las Adicciones (CONADIC), Centro Nacional para la Prevención y el Control de las Adicciones (CENADIC), National Institute on Drug Abuse-Clinical Trials Network (NIDA-CTN). A special acknowledgment for their institutional and active contribution in this study: Clínica de Trastornos Adictivos of the INPRFM, Centros de Integración Juvenil A. C. (CIJ), Consejo Estatal contra las Adicciones of Puebla (CECAP). This publication stems from the project “Development of a Clinical Trial Network on Addiction and Mental Health in Mexico” funded by a grant from the U.S. Department of State (Grant No. SINLEC11GR0015). The U.S. Department of State had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication. Clinical Trial Registration: ISRCTN registry No. ISRCTN91657311. Address correspondence to Rodrigo Marín-Navarrete, PhD, Clinical Trials Unit on Addiction and Mental Health, Instituto Nacional de Psiquiatría Ramón de la Fuente, Clz. México-Xochimilco #101, Col. San Lorenzo Huipulco, Deleg. Tlalpan, Mexico City 14370, Mexico; E-mail: rmarin@inprf.gob.mx
Publisher Copyright:
© 2014 Informa Healthcare USA, Inc.
Copyright:
Copyright 2015 Elsevier B.V., All rights reserved.
PY - 2014/11/10
Y1 - 2014/11/10
N2 - Background: Baseline patients' characteristics are critical for treatment planning, as these can be moderators of treatment effects. In Mexico, information on treatment seekers with substance use disorders is scarce and limited to demographic characteristics. Objective: This paper presents and analyses demographic characteristics, substance use related problems, clinical features, and addiction severity in a sample of treatment seekers from the first multi-site randomized clinical trial implemented in the Mexican Clinical Trials Network on Addiction and Mental Health. Methods: A total of 120 participants were assessed prior randomization. Chi square or F-tests were used to compare sites across variables. Spearman correlation was used to associate negative consequences of substance use and motivation to change. Results: The majority of participants were men, and the most prevalent substances reported were alcohol, marijuana, and cocaine. Participants were predominantly on the contemplation or action stage of change, and this was correlated with the perception of the negative consequences associated with substance use. Participants reported a high prevalence of substance use related problems. Conclusions: Substance use related problems, clinical features, and addiction severity reported by treatment seekers are important characteristics to take into account when planning treatment as they facilitate tailoring treatment to meet patients' needs.
AB - Background: Baseline patients' characteristics are critical for treatment planning, as these can be moderators of treatment effects. In Mexico, information on treatment seekers with substance use disorders is scarce and limited to demographic characteristics. Objective: This paper presents and analyses demographic characteristics, substance use related problems, clinical features, and addiction severity in a sample of treatment seekers from the first multi-site randomized clinical trial implemented in the Mexican Clinical Trials Network on Addiction and Mental Health. Methods: A total of 120 participants were assessed prior randomization. Chi square or F-tests were used to compare sites across variables. Spearman correlation was used to associate negative consequences of substance use and motivation to change. Results: The majority of participants were men, and the most prevalent substances reported were alcohol, marijuana, and cocaine. Participants were predominantly on the contemplation or action stage of change, and this was correlated with the perception of the negative consequences associated with substance use. Participants reported a high prevalence of substance use related problems. Conclusions: Substance use related problems, clinical features, and addiction severity reported by treatment seekers are important characteristics to take into account when planning treatment as they facilitate tailoring treatment to meet patients' needs.
KW - Addiction severity
KW - Outpatient treatment
KW - Substance use disorders
KW - Treatment seekers
UR - http://www.scopus.com/inward/record.url?scp=84911925139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84911925139&partnerID=8YFLogxK
U2 - 10.3109/10826084.2014.931972
DO - 10.3109/10826084.2014.931972
M3 - Article
C2 - 25014615
AN - SCOPUS:84911925139
VL - 49
SP - 1784
EP - 1794
JO - Substance Use and Misuse
JF - Substance Use and Misuse
SN - 1082-6084
IS - 13
ER -